1-Hydroxy-2,3,4,7-tetramethoxyxanthoneCAS# 14103-09-4 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 14103-09-4 | SDF | Download SDF |
| PubChem ID | 5318358 | Appearance | Yellow powder |
| Formula | C17H16O7 | M.Wt | 332.3 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1-hydroxy-2,3,4,7-tetramethoxyxanthen-9-one | ||
| SMILES | COC1=CC2=C(C=C1)OC3=C(C2=O)C(=C(C(=C3OC)OC)OC)O | ||
| Standard InChIKey | MIPXRVRWIMVNPA-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H16O7/c1-20-8-5-6-10-9(7-8)12(18)11-13(19)15(21-2)17(23-4)16(22-3)14(11)24-10/h5-7,19H,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 1-Hydroxy-2,3,4,7-tetramethoxy-xanthone can cause vasodilation in the coronary artery pre-contracted with 1uM 5-hydroxytryptamine (5-HT), with the EC 50 value of 6.6±1.4 uM. 2. 1-Hydroxy-2,3,4,7-tetramethoxyxanthone can effectively inhibit the osteoclast differentiation in a co-culture system with mouse osteoblastic calvarial cells and bone marrow cells. |
1-Hydroxy-2,3,4,7-tetramethoxyxanthone Dilution Calculator
1-Hydroxy-2,3,4,7-tetramethoxyxanthone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0093 mL | 15.0466 mL | 30.0933 mL | 60.1866 mL | 75.2332 mL |
| 5 mM | 0.6019 mL | 3.0093 mL | 6.0187 mL | 12.0373 mL | 15.0466 mL |
| 10 mM | 0.3009 mL | 1.5047 mL | 3.0093 mL | 6.0187 mL | 7.5233 mL |
| 50 mM | 0.0602 mL | 0.3009 mL | 0.6019 mL | 1.2037 mL | 1.5047 mL |
| 100 mM | 0.0301 mL | 0.1505 mL | 0.3009 mL | 0.6019 mL | 0.7523 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- PACOCF3
Catalog No.:BCC7074
CAS No.:141022-99-3
- Gama-Tocotrienol
Catalog No.:BCN3720
CAS No.:14101-61-2
- Frangulin B
Catalog No.:BCC8175
CAS No.:14101-04-3
- 2-Thiouracil
Catalog No.:BCC4752
CAS No.:141-90-2
- Malonic acid
Catalog No.:BCN8534
CAS No.:141-82-2
- 2-Aminoethanol
Catalog No.:BCN1756
CAS No.:141-43-5
- Ricinoleic acid
Catalog No.:BCC8248
CAS No.:141-22-0
- Nerylacetate
Catalog No.:BCN3802
CAS No.:141-12-8
- Benzo-15-crown 5-ether
Catalog No.:BCC8849
CAS No.:14098-44-3
- Benzo-18-crown-6 ether
Catalog No.:BCC8850
CAS No.:14098-24-9
- (2R,3S)-Chlorpheg
Catalog No.:BCC6805
CAS No.:140924-23-8
- 6-Hydroxy-5,6-dehydrosugiol
Catalog No.:BCN3127
CAS No.:140923-35-9
- Xanomeline oxalate
Catalog No.:BCC4146
CAS No.:141064-23-5
- JNK-IN-8
Catalog No.:BCC1673
CAS No.:1410880-22-6
- 12-Hydroxydodecanoic Acid
Catalog No.:BCN8405
CAS No.:505-95-3
- TRAP-6
Catalog No.:BCC3957
CAS No.:141136-83-6
- Epiguajadial B
Catalog No.:BCN4075
CAS No.:1411629-26-9
- 2-(Dimethylaminomethyl)-2-propanol
Catalog No.:BCN1774
CAS No.:14123-48-9
- Btk inhibitor 1
Catalog No.:BCC4238
CAS No.:1412418-47-3
- Asenapine hydrochloride
Catalog No.:BCC1371
CAS No.:1412458-61-7
- QS-21
Catalog No.:BCC8243
CAS No.:141256-04-4
- PEPA
Catalog No.:BCC5951
CAS No.:141286-78-4
- Orobanchyl acetate
Catalog No.:BCN7779
CAS No.:1413843-71-6
- Trachelanthamine
Catalog No.:BCN2041
CAS No.:14140-18-2
Vasodilatory actions of xanthones isolated from a Tibetan herb, Halenia elliptica.[Pubmed:19403292]
Phytomedicine. 2009 Dec;16(12):1144-50.
In this study, six major xanthones, isolated and identified from Halenia elliptica were investigated for their vasodilatory actions in isolated rat coronary artery. The xanthones, including 1-hydroxy-2,3,5-trimethoxy-xanthone (HM-1), 1-hydroxy-2,3,4,7-tetramethoxy-xanthone (HM-2), 1-hydroxy-2,3,4,5-tetramethoxy-xanthone (HM-3), 1,7-dihydroxy-2,3,4,5-tetramethoxy-xanthone (HM-4), 1,5-dihydroxy-2,3-dimethoxy-xanthone (HM-5) and 1,7-dihydroxy-2,3-dimethoxy-xanthone (HM-7) caused vasodilation in the coronary artery pre-contracted with 1 microM 5-hydroxytryptamine (5-HT), with EC(50) values ranging from 1.4+/-0.1 microM (HM-1) to 6.6+/-1.4 microM (HM-2). The EC(50) values of the other xanthones were between those of HM-1 and HM-2. Removal of endothelium of the coronary artery led to decreases in the vasorelaxant effects of HM-1, HM-7 but not HM-2, HM-3, HM-4 and HM-5. Our results showed that xanthones isolated from Halenia elliptica are vasoactive substances which exhibit either endothelium-dependent or endothelium-independent mechanisms in rat coronary artery. The potency and mechanism(s) of the vasorelaxant effects of these xanthones may be relevant to the structure-activity differences in the level and the position of the substituent groups with the primary xanthone structure.
Inhibitors of bone resorption from Halenia corniculata.[Pubmed:18704326]
Arch Pharm Res. 2008 Jul;31(7):850-5.
Eleven xanthones (1-11), three flavonoids (12-14) and three secoiridoids (15-17) were isolated from the aerial parts of Halenia corniculata. Among those compounds, 1-hydroxy-2,3,4,5-tetramethoxyxanthone (1), 1-Hydroxy-2,3,4,7-tetramethoxyxanthone (2), 1-hydroxy-2,3,4,5,7-pentamethoxyxanthone (3), 1-hydroxy-2,3,5-trimethoxyxanthone (4), 1,8-dihydroxy-3,5-dimethoxyxanthone (7), and luteolin (12), at the concentration of 1 microg/mL, effectively inhibited the osteoclast differentiation in a co-culture system with mouse osteoblastic calvarial cells and bone marrow cells. Notably, compounds 1, 3, and 4 exhibited, in a dose-dependent manner, significant inhibition of osteoclast differentiation even at a low concentration (0.01 microg/mL). All the inhibitory compounds, except for compound 7, significantly reduced the pit formation on the dentine slice compared with the control group. For the survival of the mature osteoclasts, compounds 1-4 and 12 (1 microg/mL), significantly decreased the survival number through induction of cell apoptosis, and compound 4 exhibited a significant inhibitory effect on osteoclast survival even at the low concentration of 0.1 microg/mL.
